[1] Xu P, Yang M, Liu Y, et al. Breast non-mass-like lesions on contrast-enhanced ultrasonography:Feature analysis, breast image reporting and data system classification assessment[J]. World Journal of Clinical Cases, 2020,8(4):700-712. [2] Zhang W Y, Xiao X Y, Xu X L, et al. Non-mass breast lesions on ultrasound:Feature exploration and multimode ultrasonic diagnosis[J]. Ultrasound in Medicine & Biology, 2018,44(8):1703-1711. [3] Lalji U, Lobbes M. Contrast-enhanced dual-energy mammography:A promising new imaging tool in breast cancer detection[J]. Women's Health(London, England), 2014,10(3):289-298. [4] Wang M, Feng H L, Liu Y Q, et al. Angiogenesis research in mouse mammary cancer based on contrast-enhanced ultrasonography:Exploratory study[J]. Academic Radiology, 2018,25(7):889-897. [5] 姚晓松, 张颖, 陈菲, 等. BI-RADS分级诊断标准在乳腺疾病超声诊断中的应用[J]. 中国临床研究, 2012,25(3):283-284. [6] D'Orsi C J, Mendelson E B, Morris E. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System[EB/OL]. 2013:22-23. [7] 刘健, 高云华, 苟凌云, 等. 超声造影在乳腺局灶性腺病诊断中的应用价值[J]. 中华超声影像学杂志, 2014,23(8):686-689. [8] Alaoui M'hamdi H, Abbad F, Rais H, et al. Rare variant of metaplastic carcinoma of the breast:A case report and review of the literature[J]. Journal of Medical Case Reports, 2018,12(1):1-5. [9] Goto M, Yuen S, Akazawa K, et al. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy[J]. European Radiology, 2012,22(6):1255-1264. [10] Kapetas P, Clauser P, Woitek R, et al. Quantitative multiparametric breast ultrasound:Application of contrast-enhanced ultrasound and elastography leads to an improved differentiation of benign and malignant lesions[J]. Investigative Radiology, 2019,54(5):257-264. [11] Cheng M, Tong W, Luo J, et al. Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications[J]. Clinical Radiology, 2020,75(12):934-941. [12] Wu J, Chen D C. Contrast-enhanced ultrasonography:A promising method for blood flow and perfusion evaluation in critically ill patients[J]. Chinese Medical Journal, 2018,131(10):1135-1137. [13] Amadori M, Barone D, Scarpi E, et al. Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer[J]. European Radiology, 2018,28(7):2969-2978. [14] Moschouris H, Stamatiou K, Kalokairinou-Motogna M, et al. Early post-interventional sonographic evaluation of prostatic artery embolization. A promising role for contrast-enhanced ultrasonography (CEUS)[J]. Medical Ultrasonography, 2018,20(2):134-140. [15] Yuan H X, Wang W P, Guan P S, et al. Contrast-enhanced ultrasonography in differential diagnosis of focal gallbladder adenomyomatosis and gallbladder cancer[J]. Clinical Hemorheology and Microcirculation, 2018,70(2):201-211. [16] Fedon C, Rigon L, Arfelli F, et al. Dose and diagnostic performance comparison between phase-contrast mammography with synchrotron radiation and digital mammography:A clinical study report[J]. Journal of Medical Imaging, 2018,5(1):013503. [17] Saimura M, Koga K, Anan K, et al. Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors[J]. Breast Cancer, 2018,25(4):470-478. [18] Futai R, Sanuki T, Sawa H, et al. A case of intracholecystic papillary neoplasm of the gallbladder (ICPN) examined using contrast-enhanced endoscopic ultrasonography[J]. The Japanese Journal of Gastro-Enterology, 2018,115(1):117-125. |